InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Rottinghaus Scott T.. Director active across 1 company, notably Enanta Pharmaceuticals INC. In total, 8 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €71k. History available since 8 August 2022. The latest transaction was disclosed on 12 February 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
8 of 8 declarations